Ketogenic Diet and Cardiovascular Health: A Practical Guide to Metabolic Heart Risk
- Marek Drzewiecki
- May 12
- 10 min read
Cardiovascular health is best approached with clarity, not fear.
For many years, heart health has often been reduced to a single number: cholesterol. Cholesterol is important, but it is only one part of a much wider metabolic picture.
A stronger and more responsible approach looks at the whole person: blood sugar, insulin resistance, triglycerides, HDL cholesterol, LDL cholesterol, ApoB, blood pressure, inflammation, waist size, lifestyle, family history and, where appropriate, direct evidence of plaque.
In clinical studies, low-carbohydrate diets often reduce triglycerides, increase HDL cholesterol, support weight loss, improve blood glucose control and may help reduce blood pressure.
At the same time, LDL cholesterol and ApoB can rise in some people on a ketogenic diet, especially in lean, metabolically healthy individuals. This does not mean the diet has automatically become harmful, and it also does not mean the rise should be ignored. It means the response needs to be understood properly.
The best approach is metabolic leadership.
Recent research, including the 2026 Keto-CTA preprint in Lean Mass Hyper-Responders, suggests that cardiovascular risk in ketogenic diet users may need a more personalised assessment than LDL cholesterol alone.
This is especially relevant when high LDL-C appears together with high HDL, low triglycerides, low insulin resistance and low baseline plaque burden.
Still, the responsible position remains clear: cardiovascular health should be measured carefully and interpreted intelligently.
A ketogenic diet can be a powerful tool for improving metabolic heart health, but powerful tools require structure. The goal is to reduce metabolic pressure, support blood sugar control, improve insulin sensitivity, lower triglycerides, monitor LDL-C and ApoB, and build a way of eating that supports long-term cardiovascular resilience.
This article explains how to approach ketogenic nutrition for cardiovascular health with calm authority, science, and practical decision-making.
A stronger cardiovascular assessment looks at the whole risk pattern:
triglycerides
HDL cholesterol
LDL cholesterol
ApoB
blood pressure
blood glucose
insulin resistance
body weight
waist size
inflammation
smoking status
family history
Lp(a)
coronary artery calcium score, where appropriate
coronary CT angiography, where appropriate
This matters because many people with cardiovascular risk also have metabolic dysfunction. They may have high triglycerides, low HDL, high blood pressure, abdominal weight gain, poor blood sugar control, fatty liver, insulin resistance or metabolic syndrome.
A well-formulated low-carbohydrate or ketogenic diet may improve several of these risk markers, especially in people with insulin resistance, obesity, type 2 diabetes or metabolic syndrome.
The strongest approach is calm, structured and measured:
Look at the full cardiovascular pattern. Monitor the response. Adjust intelligently.
1. Cardiovascular Health Is More Than One Marker
Atherosclerosis and cardiovascular disease develop through many interacting factors. LDL cholesterol and ApoB are important, but they do not exist in isolation.
For many people with metabolic syndrome, the common pattern is:
high triglycerides
low HDL cholesterol
high fasting glucose
high insulin
high blood pressure
central obesity
inflammation
This pattern often reflects poor metabolic regulation.
A low-carbohydrate or ketogenic diet may improve this pattern by reducing carbohydrate load, improving blood sugar control, lowering insulin demand, supporting fat loss and improving triglyceride/HDL patterns.
A 2012 systematic review and meta-analysis by Santos and colleagues found that low-carbohydrate diets were associated with significant improvements in body weight, triglycerides, HDL cholesterol, blood pressure, fasting glucose, insulin and inflammatory markers.
Actionable steps
Look beyond total cholesterol alone.
Ask for a full lipid panel: triglycerides, HDL, LDL and non-HDL cholesterol.
Consider ApoB where appropriate, especially if cardiovascular risk is a concern.
Track blood pressure, fasting glucose, HbA1c and waist measurement.
Review your risk pattern as a whole rather than reacting to one number in isolation.
2. Triglycerides: A Key Metabolic Risk Marker
Triglycerides are fats carried in the blood. High triglycerides are commonly linked with insulin resistance, high carbohydrate intake, excess liver fat, abdominal obesity and metabolic syndrome.
Low-carbohydrate diets often reduce triglycerides because they reduce the glucose and insulin pressure that can drive fat production in the liver.
This is one of the most consistent improvements seen in low-carbohydrate research.
A healthier triglyceride pattern often suggests better metabolic regulation, improved liver fat handling and better carbohydrate tolerance.
The practical message is:
Lower triglycerides often show that the body is moving toward better metabolic control.
Actionable steps
Check fasting triglycerides before starting.
Recheck after 3–6 months of a structured low-carbohydrate or ketogenic approach.
Reduce sugar, fruit juice, refined carbohydrates, alcohol excess and frequent snacking.
Support fat loss if waist size is elevated.
Add walking and resistance training to improve insulin sensitivity.
Look at triglycerides together with HDL, not in isolation.
3. HDL Cholesterol and the Triglyceride/HDL Pattern
HDL cholesterol is often described as “good cholesterol”, although its function is more complex than that simple label.
In metabolic syndrome, HDL is often low. Low HDL commonly appears together with high triglycerides, insulin resistance and central obesity.
Low-carbohydrate and ketogenic diets often increase HDL cholesterol, especially when they are based on real foods, adequate protein, natural fats and fat loss where needed.
This shift can be useful because the triglyceride/HDL pattern often reflects metabolic health.
A person with low triglycerides and higher HDL may have a very different risk pattern from someone with high triglycerides, low HDL, high blood sugar and high blood pressure.
The key point is:
The pattern matters.
Actionable steps
Track HDL together with triglycerides.
Improve the full pattern through carbohydrate reduction, fat loss, movement and better blood sugar control.
Include real foods such as eggs, oily fish, olive oil, avocado, meat and low-carbohydrate vegetables if tolerated.
Avoid ultra-processed low-carb foods as the foundation of the diet.
Use exercise, especially walking and resistance training, to support HDL and insulin sensitivity.
4. Blood Pressure and Vascular Health
High blood pressure is one of the strongest cardiovascular risk factors.
A well-formulated low-carbohydrate or ketogenic diet may support blood pressure improvement through several pathways:
weight loss
lower insulin levels
reduced fluid retention
improved blood sugar control
improved triglycerides
better metabolic health
As insulin levels fall, the kidneys may release more sodium and water. This can be one reason some people see blood pressure improve on low-carb diets.
This also means people taking blood pressure medication should monitor carefully. If blood pressure improves quickly, medication may need medical review.
The calm approach is:
Improve the metabolic environment, then monitor blood pressure responsibly.
Actionable steps
Measure blood pressure at home if you have hypertension or take medication.
Track readings at the same time of day under calm conditions.
Speak with your doctor if blood pressure begins falling and you feel dizzy or light-headed.
Support electrolytes carefully, especially sodium, potassium and magnesium.
Walk daily if possible.
Improve sleep and reduce alcohol if blood pressure is elevated.
5. Insulin Resistance and Heart Risk
Insulin resistance is strongly connected to cardiovascular risk.
When insulin resistance is present, the body often shows a pattern of high triglycerides, low HDL, abdominal obesity, high blood pressure and poor glucose control. This is the classic metabolic syndrome pattern.
A ketogenic diet may help by reducing glucose intake and lowering the need for insulin. This can improve blood sugar control and support fat loss, both of which can improve the overall cardiovascular risk picture.
This is why heart health should be connected to metabolic health.
#
A heart-health strategy should support blood sugar, insulin sensitivity, body composition and inflammation, not only cholesterol.
Actionable steps
Ask for HbA1c, fasting glucose and fasting insulin if insulin resistance is suspected.
Track waist measurement as a simple marker of central fat.
Reduce refined carbohydrates and sugar.
Build protein-based meals with natural fats and low-carbohydrate vegetables if tolerated.
Walk after meals to improve glucose handling.
Add resistance training to improve insulin sensitivity.
6. LDL Cholesterol and ApoB: Important Markers That Need Context
LDL cholesterol and ApoB matter because ApoB-containing particles are involved in atherosclerosis. In standard cardiovascular medicine, higher ApoB and higher LDL-C are generally treated as important risk factors.
At the same time, ketogenic diets create a special situation because LDL-C responses vary widely.
Some people see LDL-C stay similar.Some see LDL-C decrease.Some see LDL-C rise significantly.
This is especially seen in a subgroup often called Lean Mass Hyper-Responders, or LMHRs.
This pattern typically includes:
high LDL-C
high HDL-C
low triglycerides
leanness
good insulin sensitivity
often low carbohydrate intake
This pattern has created an important scientific question:
Does very high LDL-C on keto carry the same risk in lean, metabolically healthy people as high LDL-C in the context of insulin resistance and metabolic syndrome?
The honest answer is that the science is still developing.
The responsible approach is to respect both sides:
LDL-C and ApoB should be monitored carefully, and the wider metabolic context should also be considered.
Actionable steps
Check LDL-C before starting keto if cardiovascular risk is relevant.
Consider ApoB for a clearer view of atherogenic particle number.
Check triglycerides, HDL, glucose, HbA1c, blood pressure and waist together.
Consider Lp(a), especially with family history of early heart disease.
Recheck lipids after 3–6 months.
Discuss significant LDL-C or ApoB increases with a qualified healthcare professional.
7. The Keto-CTA Study: A More Personalised View of LDL-C on Keto
A major recent study has added important nuance to this discussion.
The paper is:
The Impact of Sustained LDL-C Elevation on Plaque Changes: Primary Coronary Plaque Progression Results from the Keto-CTA Study
Budoff, Norwitz, Feldman, Soto-Mota and colleagues.
Published as a medRxiv preprint on 16 January 2026.
This study followed 100 lean ketogenic diet users with the LMHR or near-LMHR pattern: high LDL-C, high HDL-C and low triglycerides. Participants underwent coronary CT angiography to assess plaque changes over one year.
The main analysis used QAngio methodology, with HeartFlow AI-enabled plaque analysis as a blinded confirmatory method.
The participants were lean, with a mean BMI of around 22.5 kg/m². At baseline, 57% had a coronary artery calcium score of zero. After one year, 54% still had CAC of zero, and 81% had CAC below 100.
The median increase in non-calcified plaque volume was 5.6 mm³, described as a 37% relative increase. The study reported that baseline plaque burden predicted future plaque progression, while ApoB levels and cumulative LDL-C exposure did not predict plaque progression in this specific LMHR/near-LMHR group over one year.
This matters because it challenges the simple idea that very high LDL-C on keto always equals rapid plaque progression in every person.
But the cautious interpretation is essential.
This study does not prove that high LDL-C or high ApoB is harmless. It was a preprint, the follow-up period was short, and the population was very specific: lean, metabolically healthy ketogenic diet users with high HDL and low triglycerides.
The grounded interpretation is:
In some lean, metabolically healthy keto-adapted people, cardiovascular risk may require a more personalised assessment than LDL-C alone. But high LDL-C and ApoB still deserve careful monitoring and medical discussion.
Actionable steps
If LDL-C rises significantly on keto, assess the whole pattern: HDL, triglycerides, ApoB, blood pressure, glucose, HbA1c, insulin resistance, inflammation and family history.
Consider Lp(a), especially if there is family history of early cardiovascular disease.
Consider CAC scoring or coronary CT angiography where clinically appropriate.
If baseline plaque is present, take it seriously, because baseline plaque predicted future plaque progression in the Keto-CTA study.
Review saturated fat intake if LDL-C or ApoB rises significantly.
Discuss results with a clinician who understands both cardiovascular risk and low-carbohydrate diets.
8. Food Quality Matters for Cardiovascular Keto
A ketogenic diet can be built in different ways.
For cardiovascular health, food quality matters.
A stronger approach focuses on:
adequate protein
oily fish
eggs if tolerated
olive oil
avocado
low-carbohydrate vegetables if tolerated
mineral support
reduced sugar
reduced refined carbohydrates
minimal ultra-processed foods
A weaker approach relies heavily on processed meats, processed keto snacks, excessive cream, constant cheese, low protein and little monitoring.
The best cardiovascular keto plan is:
low carb, nutrient-dense, personalised and measured.
Actionable steps
Build meals around whole foods.
Include oily fish such as salmon, sardines or mackerel if tolerated.
Use olive oil and avocado as useful fat options.
Use butter, cheese and cream according to your lipid response and tolerance.
Reduce ultra-processed foods, including processed keto products.
Monitor digestion, energy, lipids and blood pressure.
9. Inflammation and Cardiovascular Risk
Inflammation can contribute to cardiovascular risk, especially when combined with insulin resistance, obesity, poor sleep, smoking, stress and high blood sugar.
A ketogenic diet may reduce inflammatory pressure in some people by improving metabolic health, supporting fat loss and reducing glucose swings.
This is especially relevant when cardiovascular risk appears together with:
obesity
type 2 diabetes
metabolic syndrome
fatty liver
high triglycerides
high blood pressure
The wider metabolic picture matters.
When the internal environment becomes more stable, cardiovascular markers may move in a better direction.
Actionable steps
Ask about hs-CRP if inflammation is a concern.
Improve blood sugar control and waist size.
Prioritise sleep, as poor sleep can raise inflammatory and cardiovascular stress.
Reduce alcohol excess and ultra-processed foods.
Use walking, resistance training and stress reduction as part of the plan.
Track energy, recovery, mood and pain alongside blood markers.
10. A Calm Starting Framework
Step 1: Assess your baseline
Check blood pressure, lipids, ApoB, glucose, HbA1c, waist and weight.
Step 2: Reduce refined carbohydrates
Start with sugar, sweet drinks, bread, pasta, rice, cereals, pastries and ultra-processed snacks.
Step 3: Build stable meals
Use protein, natural fats and low-carbohydrate vegetables if tolerated.
Step 4: Improve fat quality
Use a balance of animal fats and unsaturated fats according to your response. Include oily fish and olive oil if tolerated.
Step 5: Add movement
Walking after meals and resistance training support glucose control, blood pressure and insulin sensitivity.
Step 6: Monitor LDL-C and ApoB
If they rise significantly, review saturated fat intake, thyroid status, weight-loss phase, family history, Lp(a) and overall risk.
Step 7: Consider plaque assessment where appropriate
If cardiovascular risk is unclear, discuss CAC scoring or coronary CT angiography with a clinician.
Step 8: Adjust with intelligence
Recheck markers after 3–6 months. Adjust saturated fat, protein, carbohydrates, calories, electrolytes and activity based on real data.
This is grounded cardiovascular leadership:
measure the risk pattern, reduce metabolic pressure, respect lipid markers, assess plaque where appropriate, and adjust with intelligence.
Conclusion: Cardiovascular Health Through Metabolic Control
A well-formulated low-carbohydrate or ketogenic diet may improve several cardiovascular risk markers, especially in people with insulin resistance, obesity, type 2 diabetes or metabolic syndrome.
The most consistent benefits are often seen in triglycerides, HDL cholesterol, blood pressure, body weight, waist size and blood sugar control. These changes suggest improved metabolic regulation.
LDL-C and ApoB responses vary. Some people, especially lean ketogenic diet users, may develop the Lean Mass Hyper-Responder pattern: high LDL-C, high HDL-C and low triglycerides.
The 2026 Keto-CTA preprint followed 100 lean ketogenic diet users with this pattern and found that baseline plaque burden predicted future plaque progression, while ApoB and cumulative LDL-C exposure did not predict plaque progression over one year in that specific group. This is important and worth watching, but it is preprint evidence, short-term, and specific to a narrow population.
The responsible conclusion is balanced:
High LDL-C on keto should not be dismissed. It should be assessed within the full cardiovascular risk picture.
The strongest approach is calm, structured and individual.
Need calm, structured guidance with ketogenic nutrition and metabolic heart health?
If you are interested in a low-carbohydrate or ketogenic approach, it is important to build the diet properly and understand how your body responds.
From a nutrition perspective, the focus is on creating a plan that supports stable blood sugar, better insulin sensitivity, healthy body composition, improved triglyceride/HDL patterns, steady energy and long-term metabolic health.
Arrange a Free 15-Minute Discovery Call
References
Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors
Obesity Reviews, 2012.
The Impact of Sustained LDL-C Elevation on Plaque Changes: Primary Coronary Plaque Progression Results from the Keto-CTA Study
Budoff, Norwitz, Feldman, Soto-Mota et al.
medRxiv preprint, 2026.
https://www.medrxiv.org/content/10.64898/2026.01.15.26343955v1
Carbohydrate Restriction-Induced Elevations in LDL-Cholesterol and Atherosclerosis: The KETO Trial
JACC Advances, 2024.
The effects of low-carbohydrate diets on cardiovascular risk factors: A meta-analysis
PLOS ONE, 2020.
Impact of the ketogenic diet as a dietary approach on cardiovascular disease risk factors: a meta-analysis of randomized clinical trials
American Journal of Clinical Nutrition, 2024.
Longitudinal Data From the KETO-CTA Study
PubMed record, 2025.
Comments